Virtual Reality and Biofeedback for Adolescents with Chronic Dizziness
Run by Boston Children's Hospital · NCT07374640 · Data updated 2026-11-12
This study tests a virtual reality and biofeedback approach to help adolescents with chronic dizziness from PPPD or vestibular migraine see if it can reduce symptoms and improve daily function.
Quick facts
| Phase | Early Phase 1 |
|---|---|
| Study type | Interventional |
| Ages | 13 Years to 25 Years |
| Sex | All |
| Enrollment | 12 (estimated) |
| Sponsor | Boston Children's Hospital Academic / other |
| Locations | 1 site (Waltham, Massachusetts) |
| Status | Recruiting |
| Started | August 3, 2026 |
| Main results expected | March 2027 |
| Study ends | May 2027 |
| Registry record updated | October 22, 2026 |
| Trial ID | NCT07374640 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adolescents with chronic dizziness due to PPPD or vestibular migraine who have not previously completed biofeedback, cognitive-behavioral therapy, or SDERP for their dizziness.
✕Probably not a fit
Patients with chronic dizziness from causes other than PPPD or vestibular migraine, or those who have already undergone relevant therapies, may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This early-phase study investigates whether a multimodal intervention using virtual reality and biofeedback can help adolescents with chronic dizziness related to PPPD or vestibular migraine. Participants are adolescents with persistent dizziness who have not previously completed certain prior therapies. The trial will apply VR-based exposure and biofeedback techniques to recalibrate visual-vestibular processing and may monitor symptoms and functional outcomes over the course of treatment. The study is conducted at Boston Children’s Hospital in collaboration with local facilities, focusing on safety, feasibility, and preliminary effectiveness. Results could inform future larger trials and pediatric dizziness management.
Why it matters
Potential benefit: If successful, participants may experience reduced dizziness and improved daily activities and school participation.
How similar studies have gone: Previous pediatric dizziness studies using multimodal approaches show promise, but this specific VR-plus-biofeedback method is exploratory in this population.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: \- Patients who previously or are currently seen in our program who have not already undergone BFB, CBT, and SDERP for treatment of their chronic dizziness. Exclusion Criteria: * Patients without chronic dizziness. * Patients for whom written consent is not available. * Patients who exhibit psychotic features, have untreated mental health conditions, or have an intellectual disability, developmental delay, or decisional impairment. * Non-English language preference patients. * Patients with a history of seizures, at risk of seizures, or who have a diagnosis of epilepsy.
Where it's running
-
Boston Children's Hospital at Waltham
Waltham, Massachusetts, United States Recruiting
Study contacts
- Principal investigator: Jacob R Brodsky, MD — Boston Children's Hospital
- Study coordinator: Jacob R Brodsky, MD
- Email: jacob.brodsky@childrens.harvard.edu
- Phone: 781-216-2849
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Rimegepant for acute vestibular migraine in adults
This study tests whether a first dose of rimegepant followed by a second dose of placebo, or first dose placebo followed by a second dose of rimegepant, helps relieve acute vestibular symptoms in adults with vestibular migraine.
-
Genetic and blood markers linked to Menière's disease and symptoms
This project will test whether common gene variants and blood markers that control inner-ear ion balance differ between people with Menière's disease, people with vestibular migraine, and people without vestibular disorders.
-
Using Glialia to treat Persistent Perceptual Postural Dizziness
This study is testing if a supplement called Glialia can help reduce brain inflammation in people with Persistent Perceptual Postural Dizziness compared to those who receive a placebo.
-
International Headache Registry
This study is collecting information from people aged 4 to 99 who have headaches or related conditions to see how these issues affect their health and treatment over time.
-
Registry for headache and vertigo conditions in China
This study is collecting information from people of all ages who have headaches or vertigo to see how different treatments work and how these conditions relate to other health issues.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.